An efficient multiplex approach to CRISPR/Cas9 gene editing in citrus

被引:2
作者
Sagawa, Cintia H. D. [1 ]
Thomson, Geoffrey [1 ]
Mermaz, Benoit [1 ]
Vernon, Corina [1 ,2 ]
Liu, Siqi [1 ]
Jacob, Yannick [1 ]
Irish, Vivian F. [1 ]
机构
[1] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA
[2] CUNY, Adv Sci Res Ctr, Environm Sci Initiat, New York, NY USA
关键词
CRISPR/Cas9; Citrus; Multiplex; Gene editing; Vector design; GENOME;
D O I
10.1186/s13007-024-01274-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
CRISPR/Cas9-mediated gene editing requires high efficiency to be routinely implemented, especially in species which are laborious and slow to transform. This requirement intensifies further when targeting multiple genes simultaneously, which is required for genetic screening or more complex genome engineering. Species in the Citrus genus fall into this category. Here we describe a series of experiments with the collective aim of improving multiplex gene editing in the Carrizo citrange cultivar using tRNA-based sgRNA arrays. We evaluate a range of promoters for their efficacy in such experiments and achieve significant improvements by optimizing the expression of both the Cas9 endonuclease and the sgRNA array. In the case of the former we find the UBQ10 or RPS5a promoters from Arabidopsis driving the zCas9i endonuclease variant useful for achieving high levels of editing. The choice of promoter expressing the sgRNA array also had a large impact on gene editing efficiency across multiple targets. In this respect Pol III promoters perform especially well, but we also demonstrate that the UBQ10 and ES8Z promoters from Arabidopsis are robust alternatives. Ultimately, this study provides a quantitative insight into CRISPR/Cas9 vector design that has practical application in the simultaneous editing of multiple genes in Citrus, and potentially other eudicot plant species.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Off-target effects in CRISPR/Cas9 gene editing
    Guo, Congting
    Ma, Xiaoteng
    Gao, Fei
    Guo, Yuxuan
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2023, 11
  • [32] Recent advances of CRISPR/Cas9 gene editing in the treatment of β-thalassemia
    Jie, Qian
    Lei, Shuangyin
    Qu, Chao
    Wu, Hao
    Liu, Yingru
    Huang, Ping
    Teng, Shuzhi
    CHINESE SCIENCE BULLETIN-CHINESE, 2022, 67 (21): : 2492 - 2508
  • [33] Gene editing by CRISPR/Cas9 in the obligatory outcrossing Medicago sativa
    Ruimin Gao
    Biruk A. Feyissa
    Mana Croft
    Abdelali Hannoufa
    Planta, 2018, 247 : 1043 - 1050
  • [34] Applications of CRISPR/Cas9 for Gene Editing in Hereditary Movement Disorders
    Im, Wooseok
    Moon, Jangsup
    Kim, Manho
    JOURNAL OF MOVEMENT DISORDERS, 2016, 9 (03) : 136 - 143
  • [35] Opportunities for CRISPR/Cas9 Gene Editing in Retinal Regeneration Research
    Campbell, Leah J.
    Hyde, David R.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2017, 5
  • [36] Efficient Editing of an Adenoviral Vector Genome with CRISPR/Cas9
    Li, Qiang
    Wang, Hui
    Gong, Chen-yu
    Chen, Zhao
    Yang, Jia-xing
    Shao, Hong-wei
    Zhang, Wen-feng
    INDIAN JOURNAL OF MICROBIOLOGY, 2021, 61 (01) : 91 - 95
  • [37] Targeted Editing of the StPDS Gene using the CRISPR/Cas9 system in Tetraploid Potato
    Ma, Jie
    Zheng, Ai-Hong
    Zhou, Ping
    Yuan, Qiao
    Wu, Rui
    Chen, Chun-Yan
    Wu, Xian-Zhi
    Zhang, Fen
    Sun, Bo
    EMIRATES JOURNAL OF FOOD AND AGRICULTURE, 2019, 31 (07): : 482 - 490
  • [38] Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA
    Zhang, Yu
    Ling, Xinyu
    Su, Xiaoxuan
    Zhang, Shilin
    Wang, Jing
    Zhang, Pingjing
    Feng, Wenjian
    Zhu, York Yuanyuan
    Liu, Tao
    Tang, Xinjing
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2020, 59 (47) : 20895 - 20899
  • [39] Engineered Metal-Organic Frameworks for Targeted CRISPR/Cas9 Gene Editing
    Rabiee, Navid
    Rabiee, Mohammad
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2025, 8 (04) : 1028 - 1049
  • [40] CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics
    Bhardwaj, Shanu
    Kesari, Kavindra Kumar
    Rachamalla, Mahesh
    Mani, Shalini
    Ashraf, Ghulam Md
    Jha, Saurabh Kumar
    Kumar, Pravir
    Ambasta, Rashmi K.
    Dureja, Harish
    Devkota, Hari Prasad
    Gupta, Gaurav
    Chellappan, Dinesh Kumar
    Singh, Sachin Kumar
    Dua, Kamal
    Ruokolainen, Janne
    Kamal, Mohammad Amjad
    Ojha, Shreesh
    Jha, Niraj Kumar
    JOURNAL OF ADVANCED RESEARCH, 2022, 40 : 207 - 221